Life Sciences

Schering-Plough settles pricing case in Missouri

Pharma Compliance Alert, November 5, 2008

Schering-Plough agreed to pay $31 million to resolve allegations of pricing fraud in Missouri, according to a release from the state Attorney General’s (AG) Office.

The settlement comes after a jury found Schering-Plough owed the state $7.3 million in compensatory damages after a two-week trial in St. Louis City Circuit Court. The settlement resolves all allegations against the company and is the largest amount the state of Missouri ever obtained in a legal case against a pharmaceutical company.

The Missouri AG filed suit against Schering-Plough in May 2005, alleging the company overcharged the Missouri Medicaid program. The AG claimed the reported average wholesale prices for drugs were often substantially higher than the prices providers actually paid, costing Missouri taxpayers millions of dollars.

Dey Pharmaceuticals paid $2.9 million to settle similar allegations in April 2006. Milan Laboratories, Teva Pharmaceuticals, Watson Pharmaceuticals, and Boehringer Ingelheim are also facing similar allegations in Missouri.

Comments

0 comments on “Schering-Plough settles pricing case in Missouri

 

Most Popular

Related Articles